药物相关牙种植体失败:系统综述与荟萃分析
该系统综述与荟萃分析纳入17篇文章,评估全身用药与种植体失败的关系。质子泵抑制剂和选择性5-羟色胺再摄取抑制剂与种植体失败率升高相关,其他药物未显示显著性。
要点
- 质子泵抑制剂与种植体失败率升高相关。
- 选择性5-羟色胺再摄取抑制剂与种植体失败率升高相关。
- 临床考虑种植治疗时应关注患者的用药史。
核心结论
- 质子泵抑制剂和选择性5-羟色胺再摄取抑制剂与种植体失败率升高相关。
研究设计与样本
- 系统综述与荟萃分析,最终纳入17篇文章进行定性评估。
主要发现
- 5项研究评估非甾体抗炎药与种植体失败的关系,2项评估选择性5-羟色胺再摄取抑制剂,2项评估质子泵抑制剂,7项评估双膦酸盐,1项评估抗高血压药。
- 质子泵抑制剂固定效应模型估计种植体失败率差异为4.3%,试验组显著高于对照组(p < 0.5)。
- 选择性5-羟色胺再摄取抑制剂使用者种植体失败率显著更高(p < 0.5),估计差异为7.5%。
- 抗高血压药仅1项研究符合纳入标准,显示抗高血压药用药者种植体存活率增加,无法进行亚组荟萃分析。
- 其他药物均未显示显著性。
关键数值与推荐
- 质子泵抑制剂:种植体失败率差异4.3%(固定效应模型,p < 0.5)。
- 选择性5-羟色胺再摄取抑制剂:种植体失败率差异7.5%(p < 0.5)。
临床怎么用
- 临床医生在考虑种植治疗时应了解患者是否使用质子泵抑制剂或选择性5-羟色胺再摄取抑制剂。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The aim of this systematic review was to investigate the association between the intake of systemic medications that may affect bone metabolism and their subsequent impact on implant failures. MATERIAL AND METHODS: Electronic and manual literature searches were conducted. Implant failure (IF) was the primary outcome, while biological/mechanical and the causes/timing associated with IF were set as secondary outcomes. Meta-analyses for the binary outcome IF and odds ratio were performed to investigate the association with medications. RESULTS: A final selection of 17 articles was screened for qualitative assessment. As such, five studies focused on evaluating the association of implant failure and non-steroidal anti-inflammatory drugs (NSAIDs), two on selective serotonin reuptake inhibitors (SSRIs), two on proton pump inhibitors (PPIs), seven on bisphosphonates (BPs), and one on anti-hypertensives (AHTNs). For PPIs, the fixed effect model estimated a difference of IF rates of 4.3%, indicating significantly higher IF rates in the test compared to the control group (p < 0.5). Likewise, for SSRIs, the IF was shown to be significantly higher in the individuals taking SSRIs (p < 0.5) as estimated a difference of 7.5%. No subset meta-analysis could be conducted for AHTNs medications as only one study fulfilled the inclusion criteria, which revealed an increased survival rate of AHTN medication. None of the other medications yielded significance. CONCLUSIONS: The present systematic review showed an association of PPIs and SSRIs with an increased implant failure rate. Hence, clinicians considering implant therapy should be aware of possible medication-related implant failures.
引用
- Chappuis V, Avila-Ortiz G, Araújo MG, et al. Medication-related dental implant failure: Systematic review and meta-analysis. Clin Oral Implants Res. 2018. PMID: 30328197. doi:10.1111/clr.13137
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。